#None #DAXXIFY #Sisram Medical #Alma Harmony

Sisram Medical's 2024 Annual Results

Sisram Medical Ltd, a prominent global player in the consumer wellness sector, has recently unveiled its audited consolidated annual results for the fiscal year concluded on December 31, 2024. Despite facing economic challenges, the company reported its revenue at $349.1 million, marking a decline of 2.8% year-over-year. However, the organization exhibited resilience, showcasing strategic product launches that drove growth in key markets, particularly in Asia, Europe, and the Middle East, while North America saw a decrease.

Revenue Breakdown

The total revenue, with 87% derived from direct sales, reflects a remarkable increase from 78% in the previous year. Specifically, revenue in the Asia-Pacific region stood at $116.2 million, rising by 6% year-on-year. The European, Middle Eastern, and African markets contributed $50.5 million and $34.6 million respectively, with notable increases of 0.7% and 27.1%. Conversely, North America experienced a 12.4% decline, with revenue amounting to $137.4 million.

Gross Profit and Net Profit Trends

Sisram's gross profit margin improved slightly to 62.1%, an uptick from the previous year's 61.1%. However, net profit faced a downturn, landing at $28.8 million, down 12.6% from 2023, illustrating the hurdles the company continues to navigate amidst a fluctuating market environment.

Dividend Declaration

In light of these results, the Board has proposed a final dividend of HK$0.126 per share, inclusive of tax, demonstrating its commitment to shareholder returns despite challenges.

Major Product Achievements

The year saw significant developments with the Alma Harmony™ platform leading in anti-aging solutions across various demographics. This innovative platform has exceeded expectations since its global launch, marking the most successful product introduction in Sisram's history. Additionally, the launch of the Special Edition of Soprano Titanium in the hair removal segment reflects Sisram's commitment to expanding its product offerings. This platform, which promises more efficient results, has been validated as the fastest hair removal treatment on the market according to independent research.

Further innovations included the launch of Alma IQ™, a cutting-edge skin analysis tool, enhancing patient consultation experiences. This technology is set to fortify Sisram's stronghold in the healthcare aesthetics segment.

Strategic Partnerships and Expansions

Sisram also made strides in the injectables sector, with DAXXIFY® gaining NMPA approval in mainland China. This innovative product addresses moderate to severe glabellar lines and is anticipated to significantly strengthen the company’s wellness portfolio upon its launch in 2025. Strategic alliances, notably with Prollenium to distribute Revanesse® dermal fillers, and approvals for Profhilo® injectables in Thailand, exemplify Sisram’s extensive network expansion strategy.

Operational Enhancements

The establishment of a direct sales office in Thailand in September 2024 has proven effective, driving a surge in revenue contributions from direct sales. This growth is a significant factor in bolstering Sisram’s market penetration and operational efficiencies, helping to offset declines in other regions.

Future Outlook

Looking ahead, Sisram Medical remains optimistic about its strategy to maintain a strong global presence. With a focused approach on North America and the Asia-Pacific regions, the company anticipates ongoing growth driven by product advancements and market demand. Collaboration with Hallura® will enhance its injectables portfolio, potentially igniting a surge in new opportunities for growth.

In a statement, Mr. Liu Yi, Chairman and Executive Director, emphasized the company’s commitment to aligning with market needs while enhancing profitability. Mr. Lior Dayan, CEO of Sisram and Alma, echoed this sentiment, highlighting the company's growth fueled by innovative products and market expansion.

The anticipated strides in the 2025 portfolio, including personalized skincare treatments, promise to elevate the consumer wellness experience and position Sisram Medical as a leader in the aesthetics market, aiming to redefine quality and care in beauty and wellness.

Conclusion

As Sisram Medical navigates this dynamic landscape, their proactive measures and innovative product launches showcase their commitment to enhancing quality of life globally. Their strategic focus on direct sales and robust partnerships lays a solid foundation for future success, making them a company to watch in the wellness industry.